NeuroVive rapporterar positiva prekliniska resultat i NASH
November 01, 2016 03:30 ET
|
NeuroVive Pharmaceutical AB
Lund den 1 november 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP,
OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelade idag att en av
deras cyklofilinhämmare, NVP018, har...
NeuroVive reports positive pre-clinical results in NASH
November 01, 2016 03:30 ET
|
NeuroVive Pharmaceutical AB
Lund, Sweden, November 1, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm:
NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced positive
pre-clinical results with one of its...
NeuroVive Pharmaceutical AB: Årsstämma 2017 och valberedning
October 26, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund den 26 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP,
OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att
årsstämma i NeuroVive Pharmaceutical AB (publ)...
NeuroVive Pharmaceutical AB: Annual General Meeting 2017 and Nomination Committee
October 26, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund, Sweden, October 26, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm:
NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the
Annual General Meeting of NeuroVive...
NeuroVive completes closure of Lyon subsidiary
October 25, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund, Sweden, October 25, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm:
NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that it
has completed the closure of its dormant...
NeuroVive fullföljer nedläggning av dotterbolag i Lyon
October 25, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund den 25 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP,
OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att bolaget
har fullföljt nedläggningen av det...
NeuroVive and Arbutus sign termination agreement
October 21, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund, Sweden, October 21, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm:
NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the
license agreement with Arbutus...
NeuroVive och Arbutus tecknar termineringsavtal
October 21, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund den 21 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP,
OTCQX: NEVPF), ett företag inom mitokondriell medicin, meddelar idag att
licensavtalet med Arbutus Biopharma (tidigare...
NeuroVive avbryter utvecklingen av CicloMulsion för akut njurskada
October 13, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund den 13 oktober 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP,
OTCQX: NEVPF), ett företag inom mitokondriell medicin, presenterar idag resultat
från den explorativa kliniska fas...
NeuroVive discontinues development of CicloMulsion for acute kidney injury
October 13, 2016 02:30 ET
|
NeuroVive Pharmaceutical AB
Lund, Sweden, October 13, 2016 - NeuroVive Pharmaceutical AB (Nasdaq Stockholm:
NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced results
from the exploratory clinical phase II...